Company News

Share this article:

Microsoft acquired certain assets of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics, the latter a wholly owned subsidiary of Merck. The deal bolsters Microsoft's Amalga Life Sciences platform by integrating genetic, genomic, metabolomic and proteomics data management into the platform. Microsoft furthered partnered with Merck to enhance the Amalga Life Sciences platform to “meet emerging pharmaceutical research needs,” according to a statement.

 

Merge Healthcare, a health IT solutions provider, will acquire etrials Worldwide, a clinical trials software and services company. The combined organization will provide clinical trial sponsors and contract research organizations with solutions that include both critical imaging technologies and eClinical capabilities, according to a statement.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.